Journal
PHARMACEUTICAL RESEARCH
Volume 23, Issue 7, Pages 1417-1450Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s11095-006-0284-8
Keywords
autoimmune disease; cancer; drug targeting; infections; industrial development; liposome; metabolic disease; nanoparticle; vaccine; nanotechnology
Ask authors/readers for more resources
The purpose of this expert review is to discuss the impact of nanotechnology in the treatment of the major health threats including cancer, infections, metabolic diseases, autoimmune diseases, and inflammations. Indeed, during the past 30 years, the explosive growth of nanotechnology has burst into challenging innovations in pharmacology, the main input being the ability to perform temporal and spatial site-specific delivery. This has led to some marketed compounds through the last decade. Although the introduction of nanotechnology obviously permitted to step over numerous milestones toward the development of the magic bullet proposed a century ago by the immunologist Paul Ehrlich, there are, however, unresolved delivery problems to be still addressed. These scientific and technological locks are discussed along this review together with an analysis of the current situation concerning the industrial development.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available